Tag: rare disease gene therapy insurance appeal process USA
How to Get Insurance to Cover Rare Disease Gene Therapy (2024 U.S. Guide): Medicaid Rules, Employer Benefits, Genetic Testing Eligibility & Appeal Process
Per 2024 FDA, CMS, and National Organization for Rare Disorders (NORD) data, this official 2024 U.S. buying guide breaks down how to get insurance to cover life-saving rare disease gene therapy, and help you navigate Medicaid rules, employer benefits, genetic testing eligibility, and the formal appeal process, with a Premium vs Counterfeit Models comparison to